Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin versus sitagliptin added to metformin and sulphonylurea in type 2 diabetes mellitus
2010-020053-14Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Canagliflozin add-on arm with Sitagliptin add-on arm (2 arms). Primary endpoint: Change in hemoglobin A1c. Started Jul 2010; status: completed.
02
Drugs
canagliflozinsitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-020053-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020053-14.